UK markets closed
NIKKEI 225
33,321.22 -87.17 (-0.26%) HANG SENG
16,993.44 -360.70 (-2.08%) CRUDE OIL
77.72 +1.31 (+1.71%) GOLD FUTURES
2,045.40 +5.40 (+0.26%) DOW
35,430.42 +13.44 (+0.04%) Bitcoin GBP
29,800.67 -135.63 (-0.45%)
NVO Jan 2024 90.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:33PM EST. Market open.
| Previous close | 13.00 |
| Open | 13.40 |
| Bid | 11.70 |
| Ask | 13.60 |
| Strike | 90.00 |
| Expiry date | 2024-01-19 |
| Day's range | 13.40 - 13.40 |
| Contract range | N/A |
| Volume | |
| Open interest | 707 |
ZacksEmergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine
The BARDA is exercising an option to procure additional doses of Emergent BioSolutions' (EBS) recently approved anthrax vaccine. Deliveries will likely be completed by the end of first-quarter 2024.
ZacksIs Alpine Immune Sciences (ALPN) Outperforming Other Medical Stocks This Year?
Here is how Alpine Immune Sciences, Inc. (ALPN) and Novo Nordisk (NVO) have performed compared to their sector so far this year.
ZacksMerck's (MRK) Pneumococcal Jab Shows Upbeat Responses in Study
Positive data from Merck's (MRK) phase III study on V116, an investigational, 21-valent pneumococcal conjugate vaccine, supports the immunogenicity of V116 compared to standard of care.
© 2023 Yahoo. All rights reserved.